840
Participants
Start Date
March 31, 2004
Primary Completion Date
May 31, 2013
Study Completion Date
July 31, 2013
Alprostadil
"* Active Substance: Prostaglandin E1~* Pharmaceutical Form: solution for infusion~* Concentration: 40 μg b.d.~* Route of Administration: intravenous infusion"
Placebo
"* Active Substance: Lactose~* Pharmaceutical Form: solution for infusion~* Concentration: 40 μg b.d.~* Route of Administration: intravenous infusion"
404, Pilsen
414, Ústí nad Labem
1, Karlsbad
502, Aguascalientes
505, Mérida
501, Querétaro
306, Bydgoszcz
321, Gmina Końskie
320, Krakow
314, Lublin
315, Lublin
316, Poznan
317, Poznan
301, Szczecin
304, Szczecin
307, Warsaw
308, Warsaw
309, Warsaw
318, Warsaw
319, Warsaw
312, Wroclaw
322, Zamość
246, Barnaul
205, Chelyabinsk
244, Chelyabinsk
228, Irkutsk
242, Kazan'
227, Kemerovo
201, Moscow
202, Moscow
203, Moscow
209, Moscow
219, Moscow
220, Moscow
230, Moscow
248, Moscow
231, Novosibirsk
232, Novosibirsk
222, Omsk
217, Petrozavodsk
206, Rostov-on-Don
225, Rostov-on-Don
236, Rostov-on-Don
239, Rostov-on-Don
224, Ryazan
210, Saint Petersburg
212, Saint Petersburg
213, Saint Petersburg
214, Saint Petersburg
215, Saint Petersburg
216, Saint Petersburg
218, Samara
237, Saratov
243, Tula
234, Tver'
238, Tyumen
241, Ufa
240, Volgograd
221, Yaroslavl
223, Yekaterinburg
247, Yekaterinburg
112, Dnipropetrovsk
109, Donetsk
110, Donetsk
114, Ivano-Frankivsk
111, Kharkiv
101, Kiev
102, Kiev
103, Kiev
104, Kiev
105, Kiev
106, Lviv
118, Odesa
119, Odesa
113, Uzhhorod
116, Vinnytsia
107, Zaporizhzhya
108, Zaporizhzhya
Collaborators (1)
Aptiv Solutions
INDUSTRY
UCB BIOSCIENCES GmbH
INDUSTRY